Breaking News - The Fly

Open Search

HRMY

Harmony Biosciences

$

()

Harmony Biosciences signs exclusive licensing agreement for sleeping disorders

HRMY

4/11/2024 - 08:07am

Harmony Biosciences begins Phase 3 registrational study of pitolisant in PWS

HRMY

4/3/2024 - 08:07am

Harmony Biosciences management to meet with Oppenheimer

HRMY

3/27/2024 - 04:55am

Harmony Biosciences management to meet with Oppenheimer

HRMY

3/25/2024 - 08:00am

Harmony Biosciences price target lowered by $2 at Mizuho, here's why

HRMY

2/27/2024 - 06:37am

Harmony Biosciences reports Q4 adjusted EPS 73c, consensus 48c

HRMY

2/22/2024 - 07:37am

Harmony Biosciences: FDA grants priority review for sNDA for WAKIX

HRMY

2/21/2024 - 08:07am

Harmony Biosciences' pitolisant designated Orphan Drug in Prader-Willi syndrome

HRMY

2/20/2024 - 08:07am

Harmony Biosciences price target raised by $9 at Mizuho, here's why

HRMY

2/15/2024 - 06:47am

Harmony Biosciences' treatment of PWS receives FDA orphan designation

HRMY

2/12/2024 - 18:39pm

Harmony Biosciences sees FY24 net product revenue $700M-$720M

HRMY

1/8/2024 - 08:17am

Harmony Biosciences sees Q4, FY23 net product revenue growth of over 30%

HRMY

1/8/2024 - 08:17am

Harmony Biosciences just downgraded at BofA, here's why

HRMY

1/2/2024 - 05:29am

Harmony data for Wakix in DM1 'raises several concerns,' says Goldman Sachs

HRMY

12/7/2023 - 10:30am

Harmony Biosciences' pitolisant shows positive Phase 2 results in DM1

HRMY

12/7/2023 - 08:08am